Saifuddin Sheikh
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
Papers in
-
- RNA Interference and Gene Delivery 4
- Lipid Membrane Structure and Behavior 4
- Biochemical and Molecular Research 3
- Glycosylation and Glycoproteins Research 2
-
- Amino Acid Enzymes and Metabolism 4
- Co-authors
- Henry Weiner (6 shared papers)Shoukath M. Ali (16 shared papers)Moghis U. Ahmad (14 shared papers)Ateeq Ahmad (18 shared papers)Imran Ahmad (8 shared papers)Imran Ahmad (11 shared papers)Pei-Yu Chien (4 shared papers)Li Ni (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)Journal of Clinical Oncology (3 papers)Advances in experimental medicine and biology (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- IndiaUnited StatesCzechia
In The Last Decade
Saifuddin Sheikh
37 papers receiving 794 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 110
- Pharmaceutical Science 46
- Clinical Biochemistry 46
- Molecular Biology 480
- Cancer Research 90
Countries citing papers authored by Saifuddin Sheikh
This map shows the geographic impact of Saifuddin Sheikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saifuddin Sheikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saifuddin Sheikh more than expected).
Fields of papers citing papers by Saifuddin Sheikh
This network shows the impact of papers produced by Saifuddin Sheikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saifuddin Sheikh. The network helps show where Saifuddin Sheikh may publish in the future.
Co-authors
The 25 scholars most cited alongside Saifuddin Sheikh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 132 | |
| 2 | Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation. | 2005 | 74 |
| 3 | 1997 | 71 | |
| 4 | 1997 | 65 | |
| 5 | 1998 | 52 | |
| 6 | 2005 | 47 | |
| 7 | 2010 | 45 | |
| 8 | 1996 | 43 | |
| 9 | 2005 | 37 | |
| 10 | 2013 | 33 | |
| 11 | 2004 | 33 | |
| 12 | 2010 | 32 | |
| 13 | 2010 | 25 | |
| 14 | 1997 | 23 | |
| 15 | 1996 | 18 | |
| 16 | 2009 | 17 | |
| 17 | 2005 | 16 | |
| 18 | 1993 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2014 | 6 |
About Saifuddin Sheikh
Saifuddin Sheikh is a scholar working on Molecular Biology, Biochemistry, Oncology, Clinical Biochemistry and Genetics, having authored 39 papers that have together received 846 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (6 papers), RNA Interference and Gene Delivery (4 papers), Amino Acid Enzymes and Metabolism (4 papers), Lipid Membrane Structure and Behavior (4 papers), Chemotherapy-related skin toxicity (3 papers), Biochemical and Molecular Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Biomaterials (110 citations), Pharmaceutical Science (46 citations), Clinical Biochemistry (46 citations), Molecular Biology (480 citations) and Cancer Research (90 citations). Saifuddin Sheikh has collaborated with scholars based in India, United States and Czechia. Frequent co-authors include Henry Weiner, Shoukath M. Ali, Moghis U. Ahmad, Ateeq Ahmad, Imran Ahmad, Imran Ahmad, Pei-Yu Chien, Li Ni, Ni Li and Thomas D. Hurley. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology, Advances in experimental medicine and biology, Bioorganic & Medicinal Chemistry Letters and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.